33 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
3 Unstoppable Dividend Stocks That Could Pay You for Life https://www.fool.com/investing/2024/02/17/3-unstoppable-dividend-stocks-that-could-pay-you-f/?source=iedfolrf0000001 Feb 17, 2024 - There are no certainties in life or on the stock market. These companies' dividends are about as close as we can get.
Top Research Reports for Johnson & Johnson, Walt Disney & Uber https://www.zacks.com/commentary/2223994/top-research-reports-for-johnson-johnson-walt-disney-uber?cid=CS-ZC-FT-research_daily-2223994 Feb 09, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), The Walt Disney Company (DIS) and Uber Technologies, Inc. (UBER).
7 Dividend Stocks That Pay Me More Than $500 Per Month https://www.fool.com/investing/2024/02/03/7-dividend-stocks-that-pay-me-more-than-500-per-mo/?source=iedfolrf0000001 Feb 03, 2024 - These stocks pay safe, reliable, and growing dividends.
AbbVie (ABBV) Q4 Earnings Beat, Raises Sales View for Key Drugs https://www.zacks.com/stock/news/2220511/abbvie-abbv-q4-earnings-beat-raises-sales-view-for-key-drugs?cid=CS-ZC-FT-analyst_blog|earnings_article-2220511 Feb 02, 2024 - AbbVie???s (ABBV) fourth-quarter earnings and sales beat estimates. Management hikes the 2027 forecast for new immunology drugs to more than $27 billion.
Key Takeaways From JNJ's (JNJ) Q4 Earnings Presentation https://www.zacks.com/stock/news/2216453/key-takeaways-from-jnj-s-jnj-q4-earnings-presentation?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216453 Jan 26, 2024 - J&J's (JNJ) Innovative Medicines as well as MedTech units outperform expectations in the fourth quarter. Here we discuss some highlights of its performance in the fourth quarter.
Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/01/23/johnson-johnson-jnj-q4-2023-earnings-call-transcri/?source=iedfolrf0000001 Jan 23, 2024 - JNJ earnings call for the period ending December 31, 2023.
Q4 Earnings for J&J, Procter, GE & More https://www.zacks.com/stock/news/2214313/q4-earnings-for-j-j-procter-ge-more?cid=CS-ZC-FT-ahead_of_wall_street-2214313 Jan 23, 2024 - Pre-market trading fortunes are mixed for this morning's reportees, including JNJ, PG, GE, MMM and DHI.
Johnson & Johnson (JNJ) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2214282/johnson-johnson-jnj-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2214282 Jan 23, 2024 - The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
JNJ looking to move talc powder unit to Texas ahead of bankruptcy filing: report https://seekingalpha.com/news/4056938-jnj-looking-to-move-talc-powder-unit-to-texas-ahead-of-bankruptcy-filing-report?source=feed_sector_healthcare Jan 22, 2024 - Johnson & Johnson (JNJ) is reportedly looking to relocate its LTL talc powder unit to Texas ahead of an expected third bankruptcy filing for the subsidiary. Read more here.
Alvotech (ALVO) Up on BLA Update for Two Biosimilar Candidates https://www.zacks.com/stock/news/2213525/alvotech-alvo-up-on-bla-update-for-two-biosimilar-candidates?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2213525 Jan 22, 2024 - The FDA concludes the reinspection of Alvotech's (ALVO) facility in Iceland. The company believes that it may receive approval for biosimilar candidates, AVT02 and AVT04, in the United States. Stock rises.

Pages: 1234

<Page 2>